Flixabi®

ACTIVE PRINCIPLE:
Infliximab

INDICATION:
Psoriasic arthritis
Rheumatoid Arthritis
Psoriasis
Ulcerative colitis
Crohn's disease
Ankylosing spondylitis

DATE:
07/07/2016

STATUS:
Authorized

MORE INFORMATION